Trials / Sponsors / Floor Backes, MD
Floor Backes, MD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopia Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma | Phase 2 | 2021-09-01 |
| Terminated | Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer Lynch Syndrome, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma | EARLY_Phase 1 | 2021-07-01 |